ArticleNature biomedical engineering2026

Development of an investigational epigenetic silencer therapy to transcriptionally inactivate viral DNA in chronic hepatitis B.

Yesseinia Anglero-Rodriguez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.